‘Value driver’ Hatch to scope out Colossus rare earths project for Viridis Mining in Brazil
Hatch to deliver scoping study for Colossus, beginning in March $4.5m raised for development Maiden resource due in Q2 this year Special Report: Viridis [more…]
Navigating the future of customer engagement with AI
Special Report: In today’s market, the ability for brands to stand out has become more challenging than ever. With consumer expectations at an all-time high, [more…]
Top 10 at 11: Lithium hits and AI are what’s driving the news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]
Market Highlights: Lyft stock jumps 35pc, the new Sensational Six, and 5 small caps to watch today
ASX to bounce back after a tech rally in New York Lyft jumps 35pc despite hiccup in earnings release Magnificent Seven over, now [more…]
Uranium, REE join the target list at James Bay Minerals’ flagship Joule property
High resolution surveys outline significant uranium and REE targets at James Bay Minerals’ Joule property eU reading of up to 29ppm is 8x higher than [more…]
What is Margin of Safety, and how investors could use it to find safer bets
Warren Buffett is a big believer in Margin of Safety A margin of safety allows room for error for the investor So what is it, [more…]
MoneyTalks: Why these dirt cheap explorers are catching the eye of Alto Capital’s Tony Locantro
MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s [more…]
RIU Explorers: ASX uranium opportunities could be ready to explode. Choose wisely
Uranium prices have surged, making it one of the few commodities drawing excitement from investors It’s expected to bring a number of new projects [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 15 February, 2024 – notable on the historical calendar as the date on which, in the year 399BC that [more…]
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
Private company Aravax to make peanut allergy breakthrough The company’s drug doesn’t cause severe allergic reactions during treatments And here are the recent ASX healthcare [more…]
